Department of Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Int J Stroke. 2024 Apr;19(4):422-430. doi: 10.1177/17474930231214769. Epub 2023 Nov 22.
There is growing evidence suggesting efficacy of endovascular therapy for M2 occlusions of the middle cerebral artery. More than one recanalization attempt is often required to achieve successful reperfusion in M2 occlusions, associated with general concerns about the safety of multiple maneuvers in these medium vessel occlusions.
The aim of this study was to investigate the association between the number of recanalization attempts and functional outcomes in M2 occlusions in comparison with large vessel occlusions (LVO).
Retrospective multicenter cohort study of patients who underwent endovascular therapy for primary M2 occlusions. Patients were enrolled in the German Stroke Registry at 1 of 25 comprehensive stroke centers between 2015 and 2021. The study cohort was subdivided into patients with unsuccessful reperfusion (mTICI 0-2a) and successful reperfusion (mTICI 2b-3) at first, second, third, fourth, or ⩾fifth recanalization attempt. Primary outcome was 90-day functional independence defined as modified Rankin Scale score of 0-2. Safety outcome was the occurrence of symptomatic intracranial hemorrhage. Internal carotid artery or M1 occlusions were defined as LVO and served as comparison group.
A total of 1078 patients with M2 occlusion were included. Successful reperfusion was observed in 87.1% and 90-day functional independence in 51.9%. The rate of functional independence decreased gradually with increasing number of recanalization attempts ( < 0.001). In both M2 occlusions and LVO, successful reperfusion within three attempts was associated with greater odds of functional independence, while success at ⩾fourth attempt was not. Patients with ⩾4 attempts exhibited higher rates of symptomatic intracranial hemorrhage in M2 occlusions (6.5% vs 2.7%, = 0.02) and LVO (7.2% vs 3.5%, < 0.001).
This study suggests a clinical benefit of successful reperfusion within three recanalization attempts in endovascular therapy for M2 occlusions, which was similar in LVO. Our findings reduce concerns about the risk-benefit ratio of multiple attempts in M2 medium vessel occlusions.
The data that support the findings of this study are available on reasonable request after approval of the German Stroke Registry (GSR) steering committee.
ClinicalTrials.gov Identifier: NCT03356392.
越来越多的证据表明血管内治疗对大脑中动脉 M2 闭塞的疗效。在 M2 闭塞中,通常需要多次再通尝试才能实现成功再灌注,这与人们对这些中等血管闭塞中多次操作安全性的普遍关注有关。
本研究旨在比较大血管闭塞(LVO)与 M2 闭塞患者,探讨再通尝试次数与功能结局之间的关系。
回顾性多中心队列研究纳入了 2015 年至 2021 年期间在 25 家综合卒中中心中的 1 家接受血管内治疗的原发性 M2 闭塞患者。研究队列首先分为再通不成功(mTICI 0-2a)和再通成功(mTICI 2b-3)的患者,再通尝试分别为第 1、2、3、4 或 ⩾第 5 次。主要结局为 90 天功能独立,定义为改良 Rankin 量表评分 0-2。安全性结局为症状性颅内出血的发生。颈内动脉或 M1 闭塞定义为 LVO,作为比较组。
共纳入 1078 例 M2 闭塞患者。再通成功率为 87.1%,90 天功能独立率为 51.9%。再通尝试次数的增加与功能独立率的逐渐下降相关( < 0.001)。在 M2 闭塞和 LVO 中,前 3 次再通成功与功能独立的可能性更大相关,而第 ⩾4 次再通成功则不相关。M2 闭塞中 ⩾4 次尝试的患者症状性颅内出血发生率较高(6.5%比 2.7%, = 0.02),LVO 中也较高(7.2%比 3.5%, < 0.001)。
本研究表明,在血管内治疗 M2 闭塞中,前 3 次再通成功具有临床获益,与 LVO 相似。我们的研究结果减轻了对 M2 中等血管闭塞中多次操作风险效益比的担忧。
支持本研究结果的数据可在德国卒中登记(GSR)指导委员会批准后,按合理要求提供。
ClinicalTrials.gov 标识符:NCT03356392。